The long-term outcomes of concomitant Cox-Maze IV procedure in patients with mitral valve disease and atrial fibrillation
The Journal of Thoracic and Cardiovascular Surgery · 2025-12 · 170 (6) · 1631-1638.e11
DOI: 10.1016/j.jtcvs.2025.05.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2025-12. Verfasst von Jack J Yi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiothoracic Surgery, Washington University School of Medicine, Barnes-Jewish Hospital, Saint Louis, Mo. Hauptthemen laut MEDLINE: Atrial Fibrillation, Mitral Valve, Heart Valve Diseases, Maze Procedure. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, Foundation for Barnes-Jewish Hospital, US Government National Institutes of Health.
Abstract (Originalsprache)
BACKGROUND: The most common indication worldwide for surgical ablation of atrial fibrillation (AF) is patients referred for mitral valve surgery. However, few reports have described late outcomes. This study examined 10-year outcomes in patients with AF undergoing mitral surgery with and without a concomitant Cox-Maze IV procedure (CMP-IV). METHODS: Since January 2002, 847 patients with AF and mitral valve disease underwent either mitral surgery with a concomitant CMP-IV (n = 407) or without (n = 440). The concomitant subgroups, paroxysmal (n = 163) and nonparoxysmal AF (n = 244), were compared for freedom from tachyarrhythmias and recurrence-free survival. Late survival was compared after propensity score-matching analysis. RESULTS: The concomitant procedure provided good freedom from atrial tachyarrhythmias of 80% and 65% at years 5 and 10, respectively. The freedom from symptomatic AF recurrence was 94% and 83%, respectively. Although there was no difference between atrial tachyarrhythmia recurrence-free survival between subgroups in the concomitant cohort (P = .13), there was a trend toward worse rhythm outcomes (P = .053) in patients with nonparoxysmal AF. Ten-year survival in the propensity-matched concomitant CMP-IV cohort was 54% (vs 43% without ablation), which represented a significant survival benefit in patients having concomitant ablation (P = .007). CONCLUSIONS: CMP-IV had good long-term outcomes in treating AF in patients undergoing mitral surgery and provided a significant survival benefit in patients receiving a concomitant ablation. There is recurrence in over 40% of patients at 10 years, indicating the need for continued rhythm follow-up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiothoracic Surgery, Washington University School of Medicine, Barnes-Jewish Hospital, Saint Louis, Mo.
- Division of Cardiothoracic Surgery, Washington University School of Medicine, Barnes-Jewish Hospital, Saint Louis, Mo. Electronic address: damianor@wustl.edu.
Förderung
- NHLBI NIH HHS
- Foundation for Barnes-Jewish Hospital
- US Government National Institutes of Health
Zitieren
APA
Yi, J. J., Yates, T. A., McGilvray, M., Vinyard, C., Banull, N., Sinn, L., He, J., Zemlin, C., Roberts, H. G., Schill, M. R., & Damiano, R. J. (2025). The long-term outcomes of concomitant Cox-Maze IV procedure in patients with mitral valve disease and atrial fibrillation. The Journal of Thoracic and Cardiovascular Surgery, 170(6), 1631-1638.e11. https://doi.org/10.1016/j.jtcvs.2025.05.005
Vancouver
Yi JJ, Yates TA, McGilvray M, Vinyard C, Banull N, Sinn L, et al. The long-term outcomes of concomitant Cox-Maze IV procedure in patients with mitral valve disease and atrial fibrillation. The Journal of Thoracic and Cardiovascular Surgery. 2025;170(6):1631-1638.e11. doi:10.1016/j.jtcvs.2025.05.005
BibTeX
@article{Yi2025,
author = {Yi, Jack J and Yates, Tari-Ann and McGilvray, Martha and Vinyard, Connor and Banull, Nicholas and Sinn, Laurie and He, June and Zemlin, Christian and Roberts, Harold G and Schill, Matthew R and Damiano, Ralph J},
title = {The long-term outcomes of concomitant Cox-Maze IV procedure in patients with mitral valve disease and atrial fibrillation},
journal = {The Journal of Thoracic and Cardiovascular Surgery},
year = {2025},
volume = {170},
number = {6},
pages = {1631--1638.e11},
doi = {10.1016/j.jtcvs.2025.05.005}
}
EUVIMED